Summary
Mark Baillie is a senior statistical leader with nine years of industry experience and a broader research pedigree spanning academia and national statistics, now directing biostatistics at Novartis in Basel. He combines deep expertise in experimental design, statistical modelling, machine learning and data visualization with hands-on experience across cardiovascular, metabolic and infectious disease programs. His career traces a steady progression from research fellowships and national census methodology to senior biostatistician and director-level roles, reflecting strong technical credibility and stakeholder-facing consulting. Trained with a PhD in information retrieval and text mining and an MSc in IT, he brings uncommon fluency in both computational methods and pharmaceutical medicine. Colleagues rely on him to translate complex statistical methodology into pragmatic, auditable decisions for drug development.
9 years of coding experience
8 years of employment as a software developer
Master’s Degree, ECPM (European Course in Pharmaceutical Medicine), Master’s Degree, ECPM (European Course in Pharmaceutical Medicine) at Universität Basel
MSc, Information Technology, MSc, Information Technology at The University of Glasgow